KDR and renal cell carcinoma: The effectiveness of neoadjuvant systemic therapy with VEGFR-TKIs, immune checkpoint inhibitors, and combination regimens has shown promising results in increasing the feasibility of PN in patients with high-complexity or locally advanced RCC.